Allen M, De Fusco C, Legrand F, Clementi R, Conter V, Danesino C, Janka G, Aricò M
Department of Pediatrics, University, IRCCS Policlinico San Matteo, Pavia, Italy.
Haematologica. 2001 May;86(5):499-503.
Most patients with familial hemophagocytic lymphohistiocytosis (HLH) develop the disease within the first two years of age. In a minority of cases a later occurrence has been reported, with an upper age limit of eight years. A significant concordance of the age at onset within each family has also been observed.
We report four cases of families with HLH diagnosed at an unusually late age, comprised between between 9 and 17 years; in each of these families another child developed the disease in infancy. The natural killer activity of the patients was depleted; nevertheless, we had indirect evidence that, in at least two families, mutations of the perforin gene were not causing the disease.
Such a late onset is very unusual and suggests that there is a subgroup of families with HLH in which the disease may present early or late in different members. Thus in some families with HLH the siblings might remain at risk of developing the disease for several years. Their actual risk cannot be defined until the genetic mutation is identified in each family and assessed in each member.
大多数家族性噬血细胞性淋巴组织细胞增生症(HLH)患者在两岁前发病。少数病例报告显示发病较晚,发病年龄上限为8岁。每个家族中发病年龄也存在显著一致性。
我们报告了4例HLH家族病例,其发病年龄异常晚,在9至17岁之间;在这些家族中,另有一个孩子在婴儿期发病。患者的自然杀伤活性降低;然而,我们有间接证据表明,至少在两个家族中,穿孔素基因突变并非导致该病的原因。
如此晚的发病情况非常罕见,这表明HLH家族中存在一个亚组,其中不同成员的疾病可能早发或晚发。因此,在一些HLH家族中,兄弟姐妹可能在数年内仍有发病风险。在每个家族中识别出基因突变并对每个成员进行评估之前,无法确定他们的实际风险。